Avella specialty pharmacy sterile medications: FDA inform of recall due to concerns of sterility assurance

0

#IVTEAM #Intravenous products: FDA report “Avella Specialty Pharmacy is voluntarily recalling two compounded sterile medications, Bevacizumab 1.25 mg/0.05 mL PF and Vancomycin PF (BSS) 1%. The recall is a result of concerns of sterility assurance with the specialty pharmacy’s independent testing laboratory, Front Range Laboratories. To date, Avella has not received any reports of adverse events related to the recall.”

Main page

Share.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.